MoneyWorks4Me

With no major difference for the quarter endedJune 2022 , the total revenue stood at Rs. 946.75  millions.The Net Loss for the quarter ended June 2022 is Rs. -154.37 millions as compared to Net Loss of Rs. -35.68 millions of corresponding quarter ended June 2021Operating profit for the quarter ended June 2022 decreased to 66.32 millions as compared to 174.19 millions of corresponding quarter ended June 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 946.75 904.22 4.70 946.75 904.22 4.70 3977.14 3560.59 11.70
Other Income 15.07 67.71 -77.74 15.07 67.71 -77.74 235.45 152.21 54.69
PBIDT 66.32 174.19 -61.93 66.32 174.19 -61.93 688.94 565.95 21.73
Interest 150.63 127.34 18.29 150.63 127.34 18.29 571.59 521.78 9.55
PBDT -84.31 46.85 -279.96 -84.31 46.85 -279.96 124.69 32.10 288.44
Depreciation 70.06 78.35 -10.58 70.06 78.35 -10.58 320.73 327.03 -1.93
PBT -154.37 -31.50 390.06 -154.37 -31.50 390.06 -196.04 -294.93 -33.53
TAX 0.00 4.18 0.00 0.00 4.18 0.00 4.18 3.23 29.41
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -154.37 -35.68 332.65 -154.37 -35.68 332.65 -200.22 -298.16 -32.85
Equity 108.33 108.33 0.00 108.33 108.33 0.00 108.33 108.33 0.00
PBIDTM(%) 7.01 19.26 -63.64 7.01 19.26 -63.64 17.32 15.89 8.98
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..